Clearside Biomedical (CLSD)
(Delayed Data from NSDQ)
$1.32 USD
+0.06 (4.76%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 5:30 PM ET
2-Buy of 5 2
F Value B Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.14 | 0.00% |
Earnings Summary
For their last quarter, Clearside Biomedical (CLSD) reported earnings of -$0.08 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 20.00%. Look out for CLSD's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.14 per share, reflecting a year-over-year increase of 6.67%.
Earnings History
Price & Consensus
Zacks News for CLSD
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
CLSD: What are Zacks experts saying now?
Zacks Private Portfolio Services